Here are the 8-K filings from Quantumzyme Corp (QTZM) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow QTZM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QTZM filings page.
Quantumzyme Corp. has formally changed its corporate name to Quantum Genesis AI Corp. following approval by its board on January 7, 2026 and by the holder of 79.56% of the voting power on November 30, 2025. The company filed a Certificate of Amendment with the Nevada Secretary of State on February 11, 2026, making the name change effective upon filing.
The company’s OTC trading symbol will change to “QGAI”, with the name and symbol change taking effect in the market at the open of business on February 17, 2026, as processed and announced by FINRA on February 13, 2026. These changes do not affect shareholder rights, authorized capital, issued and outstanding shares, par value, or the company’s CUSIP number.
Quantumzyme Corp. reported that its board and a majority stockholder approved an amendment to change the company’s name to Quantum Genesis AI Corp. The name change is not yet effective because the amended Articles of Incorporation still must be filed with the Nevada Secretary of State after completion of the Schedule 14C information statement process and the required 20-day waiting period under federal securities laws.
The company has also submitted a company-related action notification to FINRA to reflect the new name and request a new stock symbol. The change will not affect shareholder rights, the company’s authorized capital, issued and outstanding shares, CUSIP number, or par value. A new ticker symbol will be assigned by FINRA once it finishes reviewing the corporate action.